|
[1]
|
Guven T, Ugurlu K, Ergonul O, Celikbas AK, Gok SE, Comoglu S, et al. Neurobrucellosis: clinical and diagnostic features. Clin Infect Dis 2013;56(10):1407 − 12. http://dx.doi.org/10.1093/cid/cit072CrossRef
|
|
[2]
|
McLean DR, Russell N, Khan MY. Neurobrucellosis: clinical and therapeutic features. Clin Infect Dis 1992;15(4):582 − 90. http://dx.doi.org/10.1093/clind/15.4.582CrossRef
|
|
[3]
|
Zheng N, Wang W, Zhang JT, Cao Y, Shao L, Jiang JJ, et al. Neurobrucellosis. Int J Neurosci 2018;128(1):55 − 62. http://dx.doi.org/10.1080/00207454.2017.1363747CrossRef
|
|
[4]
|
Ceran N, Turkoglu R, Erdem I, Inan A, Engin D, Tireli H, et al. Neurobrucellosis: clinical, diagnostic, therapeutic features and outcome. Unusual clinical presentations in an endemic region. Braz J Infect Dis 2011;15(1):52 − 9. http://dx.doi.org/10.1016/S1413-8670(11)70140-4CrossRef
|
|
[5]
|
Wu TY. Clinicopathological report of brucellosis complicated with meningoencephalitis, diabetes insipidus and cirrhosis. Chin J Intern Med 1961;9(7):449. (In Chinese). |